|
OMIM |
Link |
Information gain |
01 |
|
BRCA3
|
[NCBI]
|
0.00161211
|
|
|
coronary heart disease, susceptibility to, 2
|
[NCBI]
|
0.00149945
|
|
|
RNANC
|
[NCBI]
|
0.00141328
|
|
|
neuropathy, hereditary motor and sensory, russe type
|
[NCBI]
|
0.00134341
|
|
|
MMVP2
|
[NCBI]
|
0.00106718
|
|
|
schizophrenia 12
|
[NCBI]
|
0.00106718
|
|
|
coronary heart disease, susceptibility to, 3
|
[NCBI]
|
0.00106718
|
|
|
ataxia, sensory, autosomal dominant
|
[NCBI]
|
0.000802678
|
|
|
epilepsy, partial, with variable foci
|
[NCBI]
|
0.000802678
|
|
|
candidiasis, familial chronic mucocutaneous, autosomal dominant, with thyroid disease
|
[NCBI]
|
0.000802678
|
|
|
ichthyosis prematurity syndrome
|
[NCBI]
|
0.000802678
|
|
|
RA
|
[NCBI]
|
0.000710015
|
|
|
candidiasis, familial chronic mucocutaneous, autosomal recessive
|
[NCBI]
|
0.000703286
|
|
|
AUTS7
|
[NCBI]
|
0.000703286
|
|
|
asthma-related traits, susceptibility to, 6
|
[NCBI]
|
0.000703286
|
|
|
asthma-related traits, susceptibility to, 3
|
[NCBI]
|
0.00063899
|
|
|
keratolytic winter erythema
|
[NCBI]
|
0.00063899
|
|
|
ICCA
|
[NCBI]
|
0.00063899
|
|
|
CNA1
|
[NCBI]
|
0.00063899
|
|
|
candidiasis, familial chronic mucocutaneous, autosomal dominant
|
[NCBI]
|
0.00063899
|
|
|
gout susceptibility 1
|
[NCBI]
|
0.00063899
|
|
|
epilepsy, nocturnal frontal lobe, type 2
|
[NCBI]
|
0.00063899
|
|
|
DSMA3
|
[NCBI]
|
0.00063899
|
|
|
DYT7
|
[NCBI]
|
0.000591362
|
|
|
hereditary motor and sensory neuropathy, type iic
|
[NCBI]
|
0.000591362
|
|
|
AD13
|
[NCBI]
|
0.000591362
|
|
|
AD14
|
[NCBI]
|
0.000591362
|
|
|
HMN7A
|
[NCBI]
|
0.000553553
|
|
|
MSSE
|
[NCBI]
|
0.00052223
|
|
|
corneal dystrophy, crystalline, of schnyder
|
[NCBI]
|
0.000451665
|
|
|
AMCN
|
[NCBI]
|
0.000451665
|
|
|
PARK3
|
[NCBI]
|
0.000451665
|
|
|
BRCA1
|
[NCBI]
|
0.000410162
|
|
|
mesothelioma, malignant
|
[NCBI]
|
0.000401263
|
|
|
SCA6
|
[NCBI]
|
0.000326649
|
|
|
MJD
|
[NCBI]
|
0.000324553
|
|
|
SLE
|
[NCBI]
|
0.000301631
|
|
|
hashimoto thyroiditis
|
[NCBI]
|
0.00029591
|
|
|
uric acid nephrolithiasis, susceptibility to
|
[NCBI]
|
0.000226597
|
|
|
CMT4C
|
[NCBI]
|
0.000218117
|
|
|
SCA2
|
[NCBI]
|
0.000207926
|
|
|
CF
|
[NCBI]
|
0.000199129
|
|
|
NBIA1
|
[NCBI]
|
0.000186228
|
|
|
BRCA2
|
[NCBI]
|
0.000182466
|
|
|
SCA7
|
[NCBI]
|
0.000175869
|
|
|
mucolipidosis iv
|
[NCBI]
|
0.00016578
|
|
|
myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency
|
[NCBI]
|
0.000162982
|
|
|
MLC
|
[NCBI]
|
0.000162982
|
|
|
asthma-related traits, susceptibility to, 5
|
[NCBI]
|
0.000159389
|
|
|
asthma, susceptibility to
|
[NCBI]
|
0.000153171
|
|
|
MCOLN1
|
[NCBI]
|
0.000142788
|
|
|
OCA3
|
[NCBI]
|
0.000131574
|
|
|
HHF1
|
[NCBI]
|
0.000130629
|
|
|
CMT4D
|
[NCBI]
|
0.000126903
|
|
|
MSH2
|
[NCBI]
|
0.000122748
|
|
|
congenital cataracts, facial dysmorphism, and neuropathy
|
[NCBI]
|
0.000118974
|
|
|
LGMD2H
|
[NCBI]
|
0.000118974
|
|
|
USH3
|
[NCBI]
|
0.000115549
|
|
|
CDKN2A
|
[NCBI]
|
0.000114718
|
|
|
CATCN3
|
[NCBI]
|
0.000113259
|
|
|
ACHM2
|
[NCBI]
|
0.000112405
|
|
|
LDLR
|
[NCBI]
|
0.000110221
|
|
|
NDRG1
|
[NCBI]
|
0.000109898
|
|
|
propionic acidemia
|
[NCBI]
|
0.0001095
|
|
|
holocarboxylase synthetase deficiency
|
[NCBI]
|
0.0001095
|
|
|
pseudoxanthoma elasticum, forme fruste
|
[NCBI]
|
0.000106801
|
|
|
alkaptonuria
|
[NCBI]
|
0.000104281
|
|
|
porphyria variegata
|
[NCBI]
|
0.000103475
|
|
|
LPI
|
[NCBI]
|
0.000101659
|
|
|
lynch syndrome i
|
[NCBI]
|
9.49767e-05
|
|
|
diastrophic dysplasia
|
[NCBI]
|
9.19285e-05
|
|
|
AD
|
[NCBI]
|
9.04064e-05
|
|
|
LRRK2
|
[NCBI]
|
8.78646e-05
|
|
|
amish infantile epilepsy syndrome
|
[NCBI]
|
8.5555e-05
|
|
|
CMT2K
|
[NCBI]
|
8.5555e-05
|
|
|
alzheimer disease 3
|
[NCBI]
|
8.26799e-05
|
|
|
SGCG
|
[NCBI]
|
7.98633e-05
|
|
|
AT
|
[NCBI]
|
7.80446e-05
|
|
|
PGL1
|
[NCBI]
|
7.76074e-05
|
|
|
OCA2
|
[NCBI]
|
7.53174e-05
|
|
|
ALS8
|
[NCBI]
|
7.51422e-05
|
|
|
ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis
|
[NCBI]
|
7.51422e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2f
|
[NCBI]
|
7.51422e-05
|
|
|
epilepsy, nocturnal frontal lobe, type 3
|
[NCBI]
|
7.51422e-05
|
|
|
HGD
|
[NCBI]
|
7.49571e-05
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
7.47128e-05
|
|
|
nijmegen breakage syndrome
|
[NCBI]
|
7.31665e-05
|
|
|
OCA1A
|
[NCBI]
|
7.31665e-05
|
|
|
SGSH
|
[NCBI]
|
7.23128e-05
|
|
|
CTNS
|
[NCBI]
|
7.21383e-05
|
|
|
myoclonic epilepsy of unverricht and lundborg
|
[NCBI]
|
7.21383e-05
|
|
|
PANK2
|
[NCBI]
|
7.11264e-05
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
6.94885e-05
|
|
|
BBS
|
[NCBI]
|
6.84427e-05
|
|
|
asthma-related traits, susceptibility to, 2
|
[NCBI]
|
6.84047e-05
|
|
|
HAE III
|
[NCBI]
|
6.84047e-05
|
|
|
leber congenital amaurosis, type iii
|
[NCBI]
|
6.84047e-05
|
|
|
USH1F
|
[NCBI]
|
6.84047e-05
|
|
|
MRT2
|
[NCBI]
|
6.84047e-05
|
|
|
EBN2
|
[NCBI]
|
6.84047e-05
|
|
|
HSAN3
|
[NCBI]
|
6.83041e-05
|
|
|
LI1
|
[NCBI]
|
6.74084e-05
|
|
|
SDHD
|
[NCBI]
|
6.45154e-05
|
|
|
asthma-related traits, susceptibility to, 1
|
[NCBI]
|
6.34127e-05
|
|
|
ebstein anomaly
|
[NCBI]
|
6.34127e-05
|
|
|
LCA2
|
[NCBI]
|
6.34127e-05
|
|
|
seizures, benign familial neonatal-infantile
|
[NCBI]
|
6.34127e-05
|
|
|
3-@methylglutaconic aciduria, type iii
|
[NCBI]
|
6.34127e-05
|
|
|
HPS3
|
[NCBI]
|
6.22668e-05
|
|
|
FCMD
|
[NCBI]
|
6.17207e-05
|
|
|
CCM
|
[NCBI]
|
6.17207e-05
|
|
|
OCA4
|
[NCBI]
|
5.94489e-05
|
|
|
CNA2
|
[NCBI]
|
5.94489e-05
|
|
|
bartter syndrome, infantile, with sensorineural deafness
|
[NCBI]
|
5.94489e-05
|
|
|
basal ganglia disease, adult-onset
|
[NCBI]
|
5.94489e-05
|
|
|
VAPB
|
[NCBI]
|
5.87499e-05
|
|
|
SH3TC2
|
[NCBI]
|
5.87499e-05
|
|
|
MTND6
|
[NCBI]
|
5.80244e-05
|
|
|
PPOX
|
[NCBI]
|
5.69736e-05
|
|
|
three m syndrome
|
[NCBI]
|
5.61644e-05
|
|
|
prostate cancer
|
[NCBI]
|
5.49783e-05
|
|
|
gaucher disease, type i
|
[NCBI]
|
5.37825e-05
|
|
|
CHH
|
[NCBI]
|
5.37825e-05
|
|
|
ATM
|
[NCBI]
|
5.35695e-05
|
|
|
ACHM3
|
[NCBI]
|
5.33627e-05
|
|
|
GS1
|
[NCBI]
|
5.33627e-05
|
|
|
EPD
|
[NCBI]
|
5.33627e-05
|
|
|
DFNB3
|
[NCBI]
|
5.33627e-05
|
|
|
spinal muscular atrophy, proximal, adult, autosomal dominant
|
[NCBI]
|
5.33627e-05
|
|
|
epilepsy, nocturnal frontal lobe, type 1
|
[NCBI]
|
5.33627e-05
|
|
|
MDC1C
|
[NCBI]
|
5.33627e-05
|
|
|
USH3A
|
[NCBI]
|
5.20293e-05
|
|
|
RP12
|
[NCBI]
|
5.09221e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 2
|
[NCBI]
|
5.09221e-05
|
|
|
VLDLRCH
|
[NCBI]
|
5.09221e-05
|
|
|
USH1D
|
[NCBI]
|
4.87617e-05
|
|
|
keratitis-ichthyosis-deafness syndrome, autosomal dominant
|
[NCBI]
|
4.87617e-05
|
|
|
HMBS
|
[NCBI]
|
4.8685e-05
|
|
|
SCA14
|
[NCBI]
|
4.68251e-05
|
|
|
ZNF9
|
[NCBI]
|
4.66586e-05
|
|
|
MLC1
|
[NCBI]
|
4.66586e-05
|
|
|
ITGB3
|
[NCBI]
|
4.65855e-05
|
|
|
RMRP
|
[NCBI]
|
4.56286e-05
|
|
|
FKTN
|
[NCBI]
|
4.56286e-05
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
4.55688e-05
|
|
|
CDA
|
[NCBI]
|
4.50715e-05
|
|
|
CLN5
|
[NCBI]
|
4.50715e-05
|
|
|
SACS
|
[NCBI]
|
4.50715e-05
|
|
|
HLCS
|
[NCBI]
|
4.4682e-05
|
|
|
wilson disease
|
[NCBI]
|
4.42473e-05
|
|
|
indifference to pain, congenital, autosomal recessive
|
[NCBI]
|
4.34702e-05
|
|
|
ED2
|
[NCBI]
|
4.34702e-05
|
|
|
DSMA1
|
[NCBI]
|
4.34702e-05
|
|
|
PARK2
|
[NCBI]
|
4.30881e-05
|
|
|
MLH1
|
[NCBI]
|
4.30881e-05
|
|
|
CTNS
|
[NCBI]
|
4.29923e-05
|
|
|
GDAP1
|
[NCBI]
|
4.29923e-05
|
|
|
RAPSN
|
[NCBI]
|
4.22312e-05
|
|
|
LAMA2
|
[NCBI]
|
4.22312e-05
|
|
|
trichodentoosseous syndrome
|
[NCBI]
|
4.19978e-05
|
|
|
STGD3
|
[NCBI]
|
4.19978e-05
|
|
|
LGMD2I
|
[NCBI]
|
4.19978e-05
|
|
|
sitosterolemia
|
[NCBI]
|
4.19978e-05
|
|
|
erythrocytosis, familial, 2
|
[NCBI]
|
4.19978e-05
|
|
|
USH1C
|
[NCBI]
|
4.19978e-05
|
|
|
APS1
|
[NCBI]
|
4.09884e-05
|
|
|
PRNP
|
[NCBI]
|
4.08367e-05
|
|
|
CDG2C
|
[NCBI]
|
4.06358e-05
|
|
|
LGMD2B
|
[NCBI]
|
4.06358e-05
|
|
|
PCCB
|
[NCBI]
|
4.02079e-05
|
|
|
C9
|
[NCBI]
|
3.9605e-05
|
|
|
udp-n-acetylglucosamine 2-epimerase/n-acetylmannosamine kinase
|
[NCBI]
|
3.9605e-05
|
|
|
DBT
|
[NCBI]
|
3.9605e-05
|
|
|
FFI
|
[NCBI]
|
3.94873e-05
|
|
|
PARK6
|
[NCBI]
|
3.93694e-05
|
|
|
PPAC
|
[NCBI]
|
3.93694e-05
|
|
|
severe combined immunodeficiency with sensitivity to ionizing radiation
|
[NCBI]
|
3.93694e-05
|
|
|
NDRG3
|
[NCBI]
|
3.93639e-05
|
|
|
phenylketonuria
|
[NCBI]
|
3.93355e-05
|
|
|
GJB6
|
[NCBI]
|
3.90319e-05
|
|
|
PEX7
|
[NCBI]
|
3.90319e-05
|
|
|
SCA1
|
[NCBI]
|
3.87657e-05
|
|
|
PHA
|
[NCBI]
|
3.81867e-05
|
|
|
HPC1
|
[NCBI]
|
3.81867e-05
|
|
|
longevity
|
[NCBI]
|
3.81867e-05
|
|
|
refsum disease
|
[NCBI]
|
3.81867e-05
|
|
|
acromegaly
|
[NCBI]
|
3.81867e-05
|
|
|
CYP1B1
|
[NCBI]
|
3.79645e-05
|
|
|
OPMD
|
[NCBI]
|
3.7376e-05
|
|
|
MYOC
|
[NCBI]
|
3.71034e-05
|
|
|
FTLDU
|
[NCBI]
|
3.70778e-05
|
|
|
SHEP2
|
[NCBI]
|
3.70778e-05
|
|
|
FKRP
|
[NCBI]
|
3.69877e-05
|
|
|
TGM1
|
[NCBI]
|
3.69877e-05
|
|
|
SCZD
|
[NCBI]
|
3.67066e-05
|
|
|
GEFS+
|
[NCBI]
|
3.60344e-05
|
|
|
EBN1
|
[NCBI]
|
3.60344e-05
|
|
|
PCLD
|
[NCBI]
|
3.60344e-05
|
|
|
HNA
|
[NCBI]
|
3.60344e-05
|
|
|
IBM2
|
[NCBI]
|
3.60344e-05
|
|
|
ABCC8
|
[NCBI]
|
3.57522e-05
|
|
|
ORW2
|
[NCBI]
|
3.50497e-05
|
|
|
PARK8
|
[NCBI]
|
3.50497e-05
|
|
|
MSS
|
[NCBI]
|
3.50497e-05
|
|
|
KTCN1
|
[NCBI]
|
3.50497e-05
|
|
|
CSTB
|
[NCBI]
|
3.44746e-05
|
|
|
HSAN1
|
[NCBI]
|
3.41178e-05
|
|
|
MS
|
[NCBI]
|
3.3588e-05
|
|
|
MDC1A
|
[NCBI]
|
3.32337e-05
|
|
|
CHAC
|
[NCBI]
|
3.32337e-05
|
|
|
sialuria, finnish type
|
[NCBI]
|
3.32337e-05
|
|
|
megaloblastic anemia 1
|
[NCBI]
|
3.32337e-05
|
|
|
ABCC6
|
[NCBI]
|
3.24163e-05
|
|
|
USH2A
|
[NCBI]
|
3.2393e-05
|
|
|
niemann-pick disease, type a
|
[NCBI]
|
3.2393e-05
|
|
|
glycogen storage disease iii
|
[NCBI]
|
3.2393e-05
|
|
|
biotinidase deficiency
|
[NCBI]
|
3.15919e-05
|
|
|
CMM2
|
[NCBI]
|
3.15919e-05
|
|
|
ATP7B
|
[NCBI]
|
3.12263e-05
|
|
|
TOR1B
|
[NCBI]
|
3.11242e-05
|
|
|
OPA3
|
[NCBI]
|
3.11242e-05
|
|
|
MED12L
|
[NCBI]
|
3.11242e-05
|
|
|
PBD
|
[NCBI]
|
3.08271e-05
|
|
|
ABCA4
|
[NCBI]
|
3.06753e-05
|
|
|
ENG
|
[NCBI]
|
3.01502e-05
|
|
|
LCA1
|
[NCBI]
|
3.00958e-05
|
|
|
EVC
|
[NCBI]
|
2.93953e-05
|
|
|
DFNB1
|
[NCBI]
|
2.93953e-05
|
|
|
apc gene
|
[NCBI]
|
2.92387e-05
|
|
|
usher syndrome, type i
|
[NCBI]
|
2.87233e-05
|
|
|
HPS
|
[NCBI]
|
2.85349e-05
|
|
|
STGD1
|
[NCBI]
|
2.80779e-05
|
|
|
NDRG2
|
[NCBI]
|
2.80192e-05
|
|
|
ZNF365
|
[NCBI]
|
2.80192e-05
|
|
|
CRBN
|
[NCBI]
|
2.80192e-05
|
|
|
ANXA13
|
[NCBI]
|
2.80192e-05
|
|
|
GJB2
|
[NCBI]
|
2.77048e-05
|
|
|
graves disease
|
[NCBI]
|
2.74572e-05
|
|
|
SMAX1
|
[NCBI]
|
2.64634e-05
|
|
|
DJS
|
[NCBI]
|
2.62834e-05
|
|
|
periodic fever, familial, autosomal dominant
|
[NCBI]
|
2.62834e-05
|
|
|
PXE
|
[NCBI]
|
2.6027e-05
|
|
|
CTDP1
|
[NCBI]
|
2.60055e-05
|
|
|
SLC12A1
|
[NCBI]
|
2.60055e-05
|
|
|
PFN2
|
[NCBI]
|
2.60055e-05
|
|
|
CADASIL
|
[NCBI]
|
2.46715e-05
|
|
|
walker-warburg syndrome
|
[NCBI]
|
2.46715e-05
|
|
|
MM
|
[NCBI]
|
2.46715e-05
|
|
|
RDH12
|
[NCBI]
|
2.45102e-05
|
|
|
SLC7A8
|
[NCBI]
|
2.45102e-05
|
|
|
EVC
|
[NCBI]
|
2.45102e-05
|
|
|
CUL7
|
[NCBI]
|
2.45102e-05
|
|
|
IRAK3
|
[NCBI]
|
2.45102e-05
|
|
|
DRPLA
|
[NCBI]
|
2.43611e-05
|
|
|
OPA1
|
[NCBI]
|
2.41692e-05
|
|
|
MEB
|
[NCBI]
|
2.41692e-05
|
|
|
CDG1A
|
[NCBI]
|
2.36829e-05
|
|
|
ST3GAL5
|
[NCBI]
|
2.33203e-05
|
|
|
RFXANK
|
[NCBI]
|
2.33203e-05
|
|
|
SLC35C1
|
[NCBI]
|
2.33203e-05
|
|
|
bsnd gene
|
[NCBI]
|
2.33203e-05
|
|
|
MAFK
|
[NCBI]
|
2.33203e-05
|
|
|
PDS
|
[NCBI]
|
2.32117e-05
|
|
|
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity
|
[NCBI]
|
2.32117e-05
|
|
|
GLC1A
|
[NCBI]
|
2.32117e-05
|
|
|
VHL
|
[NCBI]
|
2.26383e-05
|
|
|
HRPT2
|
[NCBI]
|
2.2332e-05
|
|
|
MAFG
|
[NCBI]
|
2.2332e-05
|
|
|
VPS13A
|
[NCBI]
|
2.2332e-05
|
|
|
POAG
|
[NCBI]
|
2.23111e-05
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
2.22596e-05
|
|
|
GBA
|
[NCBI]
|
2.21352e-05
|
|
|
HEXA
|
[NCBI]
|
2.20131e-05
|
|
|
MEN1
|
[NCBI]
|
2.1655e-05
|
|
|
SLC7A7
|
[NCBI]
|
2.14871e-05
|
|
|
GPR154
|
[NCBI]
|
2.14871e-05
|
|
|
CNGA3
|
[NCBI]
|
2.14871e-05
|
|
|
GNAT2
|
[NCBI]
|
2.14871e-05
|
|
|
DCLRE1C
|
[NCBI]
|
2.14871e-05
|
|
|
CRYBB1
|
[NCBI]
|
2.14871e-05
|
|
|
adrenoleukodystrophy, autosomal neonatal form
|
[NCBI]
|
2.14621e-05
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
2.10553e-05
|
|
|
TBCE
|
[NCBI]
|
2.07495e-05
|
|
|
BCKDHB
|
[NCBI]
|
2.07495e-05
|
|
|
GRHPR
|
[NCBI]
|
2.07495e-05
|
|
|
DM2
|
[NCBI]
|
2.06596e-05
|
|
|
DYT1
|
[NCBI]
|
2.02745e-05
|
|
|
CNGB3
|
[NCBI]
|
2.0095e-05
|
|
|
ACACB
|
[NCBI]
|
2.0095e-05
|
|
|
AIP
|
[NCBI]
|
2.0095e-05
|
|
|
SGCB
|
[NCBI]
|
1.9507e-05
|
|
|
KERA
|
[NCBI]
|
1.9507e-05
|
|
|
NR2E3
|
[NCBI]
|
1.9507e-05
|
|
|
SLC17A5
|
[NCBI]
|
1.9507e-05
|
|
|
NPHP1
|
[NCBI]
|
1.9507e-05
|
|
|
AMN
|
[NCBI]
|
1.9507e-05
|
|
|
POMGNT1
|
[NCBI]
|
1.9507e-05
|
|
|
leber optic atrophy
|
[NCBI]
|
1.90688e-05
|
|
|
HPS1
|
[NCBI]
|
1.89734e-05
|
|
|
MYO15A
|
[NCBI]
|
1.89734e-05
|
|
|
MCPH1
|
[NCBI]
|
1.89734e-05
|
|
|
IGHMBP2
|
[NCBI]
|
1.89734e-05
|
|
|
ASPM
|
[NCBI]
|
1.89734e-05
|
|
|
SAG
|
[NCBI]
|
1.89734e-05
|
|
|
SPTLC1
|
[NCBI]
|
1.89734e-05
|
|
|
HHT
|
[NCBI]
|
1.88311e-05
|
|
|
MAPT
|
[NCBI]
|
1.85406e-05
|
|
|
maple syrup urine disease
|
[NCBI]
|
1.84925e-05
|
|
|
SIX3
|
[NCBI]
|
1.8485e-05
|
|
|
OGN
|
[NCBI]
|
1.8485e-05
|
|
|
SEPT9
|
[NCBI]
|
1.8485e-05
|
|
|
IKBKAP
|
[NCBI]
|
1.80348e-05
|
|
|
C5R1
|
[NCBI]
|
1.80348e-05
|
|
|
TSD
|
[NCBI]
|
1.78683e-05
|
|
|
CLDN1
|
[NCBI]
|
1.76175e-05
|
|
|
NOTCH3
|
[NCBI]
|
1.76175e-05
|
|
|
PLA2G7
|
[NCBI]
|
1.76175e-05
|
|
|
AGXT
|
[NCBI]
|
1.76175e-05
|
|
|
PCCA
|
[NCBI]
|
1.76175e-05
|
|
|
SCN2A
|
[NCBI]
|
1.76175e-05
|
|
|
SPG3A
|
[NCBI]
|
1.72285e-05
|
|
|
AP3B1
|
[NCBI]
|
1.72285e-05
|
|
|
ME2
|
[NCBI]
|
1.72285e-05
|
|
|
AGL
|
[NCBI]
|
1.72285e-05
|
|
|
VWS
|
[NCBI]
|
1.72167e-05
|
|
|
NPC1
|
[NCBI]
|
1.6916e-05
|
|
|
SCN9A
|
[NCBI]
|
1.68644e-05
|
|
|
ELAC2
|
[NCBI]
|
1.68644e-05
|
|
|
SLC26A2
|
[NCBI]
|
1.68644e-05
|
|
|
DLL3
|
[NCBI]
|
1.65222e-05
|
|
|
RNASEL
|
[NCBI]
|
1.65222e-05
|
|
|
USH2A
|
[NCBI]
|
1.65222e-05
|
|
|
SLC45A2
|
[NCBI]
|
1.65222e-05
|
|
|
LQT1
|
[NCBI]
|
1.63345e-05
|
|
|
PTS
|
[NCBI]
|
1.61994e-05
|
|
|
C5
|
[NCBI]
|
1.61994e-05
|
|
|
SQSTM1
|
[NCBI]
|
1.61994e-05
|
|
|
MAPK8IP1
|
[NCBI]
|
1.61994e-05
|
|
|
USH1C
|
[NCBI]
|
1.61994e-05
|
|
|
TSHB
|
[NCBI]
|
1.61994e-05
|
|
|
FA
|
[NCBI]
|
1.61605e-05
|
|
|
PCDH15
|
[NCBI]
|
1.58941e-05
|
|
|
3-@beta-hydroxysteroid dehydrogenase, type ii, deficiency of
|
[NCBI]
|
1.58941e-05
|
|
|
XRCC9
|
[NCBI]
|
1.58941e-05
|
|
|
GUCY2D
|
[NCBI]
|
1.58941e-05
|
|
|
ACACA
|
[NCBI]
|
1.58941e-05
|
|
|
PRKCG
|
[NCBI]
|
1.58941e-05
|
|
|
FRAXE
|
[NCBI]
|
1.58941e-05
|
|
|
GALK1
|
[NCBI]
|
1.56045e-05
|
|
|
NCSTN
|
[NCBI]
|
1.56045e-05
|
|
|
CACNA1S
|
[NCBI]
|
1.56045e-05
|
|
|
PSEN1
|
[NCBI]
|
1.5388e-05
|
|
|
NRL
|
[NCBI]
|
1.5329e-05
|
|
|
HAMP
|
[NCBI]
|
1.5329e-05
|
|
|
CUBN
|
[NCBI]
|
1.5329e-05
|
|
|
SELP
|
[NCBI]
|
1.50664e-05
|
|
|
F12
|
[NCBI]
|
1.50664e-05
|
|
|
RPE65
|
[NCBI]
|
1.48156e-05
|
|
|
TGFBI
|
[NCBI]
|
1.45756e-05
|
|
|
PMM2
|
[NCBI]
|
1.45756e-05
|
|
|
velocardiofacial syndrome
|
[NCBI]
|
1.44864e-05
|
|
|
MIP
|
[NCBI]
|
1.43455e-05
|
|
|
SLC3A1
|
[NCBI]
|
1.43455e-05
|
|
|
metachromatic leukodystrophy
|
[NCBI]
|
1.42437e-05
|
|
|
PD
|
[NCBI]
|
1.40672e-05
|
|
|
OPA1
|
[NCBI]
|
1.39122e-05
|
|
|
IL4R
|
[NCBI]
|
1.39122e-05
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
1.37861e-05
|
|
|
DYT1
|
[NCBI]
|
1.37076e-05
|
|
|
PRKAR1A
|
[NCBI]
|
1.37076e-05
|
|
|
CHRNE
|
[NCBI]
|
1.37076e-05
|
|
|
ITGA2B
|
[NCBI]
|
1.37076e-05
|
|
|
ALS1
|
[NCBI]
|
1.35437e-05
|
|
|
IPF1
|
[NCBI]
|
1.35104e-05
|
|
|
SLC25A4
|
[NCBI]
|
1.35104e-05
|
|
|
HSPB1
|
[NCBI]
|
1.332e-05
|
|
|
ACVRL1
|
[NCBI]
|
1.3136e-05
|
|
|
FTL
|
[NCBI]
|
1.2958e-05
|
|
|
CAPN3
|
[NCBI]
|
1.2958e-05
|
|
|
ALPL
|
[NCBI]
|
1.2958e-05
|
|
|
MTRNR1
|
[NCBI]
|
1.2958e-05
|
|
|
oca2 gene
|
[NCBI]
|
1.27856e-05
|
|
|
COL10A1
|
[NCBI]
|
1.27856e-05
|
|
|
DYSF
|
[NCBI]
|
1.27856e-05
|
|
|
IL12B
|
[NCBI]
|
1.27856e-05
|
|
|
RECQL3
|
[NCBI]
|
1.27856e-05
|
|
|
NBS1
|
[NCBI]
|
1.24565e-05
|
|
|
PRPH2
|
[NCBI]
|
1.21463e-05
|
|
|
MYO7A
|
[NCBI]
|
1.21463e-05
|
|
|
FANCA
|
[NCBI]
|
1.19977e-05
|
|
|
SLC26A4
|
[NCBI]
|
1.19977e-05
|
|
|
TPI1
|
[NCBI]
|
1.18531e-05
|
|
|
PKLR
|
[NCBI]
|
1.17123e-05
|
|
|
EDN1
|
[NCBI]
|
1.15752e-05
|
|
|
GRN
|
[NCBI]
|
1.15752e-05
|
|
|
GAA
|
[NCBI]
|
1.14414e-05
|
|
|
BLM
|
[NCBI]
|
1.12924e-05
|
|
|
POLG
|
[NCBI]
|
1.10595e-05
|
|
|
CYP17A1
|
[NCBI]
|
1.10595e-05
|
|
|
CTSC
|
[NCBI]
|
1.07035e-05
|
|
|
NTRK1
|
[NCBI]
|
1.0479e-05
|
|
|
RP2
|
[NCBI]
|
1.03703e-05
|
|
|
DAO
|
[NCBI]
|
1.02638e-05
|
|
|
CRC
|
[NCBI]
|
1.01029e-05
|
|
|
FXN
|
[NCBI]
|
1.00573e-05
|
|
|
MYH7
|
[NCBI]
|
9.85875e-06
|
|
|
LBR
|
[NCBI]
|
9.76233e-06
|
|
|
HD
|
[NCBI]
|
9.68548e-06
|
|
|
F2
|
[NCBI]
|
9.6677e-06
|
|
|
PSEN2
|
[NCBI]
|
9.6677e-06
|
|
|
ZS
|
[NCBI]
|
9.59331e-06
|
|
|
HBD
|
[NCBI]
|
9.48361e-06
|
|
|
KCNQ1
|
[NCBI]
|
9.39403e-06
|
|
|
UGT1A1
|
[NCBI]
|
9.05096e-06
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
8.73012e-06
|
|
|
giant platelet syndrome
|
[NCBI]
|
8.42209e-06
|
|
|
FTD
|
[NCBI]
|
8.40814e-06
|
|
|
ARSA
|
[NCBI]
|
8.21488e-06
|
|
|
VHL
|
[NCBI]
|
8.01973e-06
|
|
|
SNCA
|
[NCBI]
|
7.87799e-06
|
|
|
factor v deficiency
|
[NCBI]
|
7.74967e-06
|
|
|
MTHFR
|
[NCBI]
|
7.6868e-06
|
|
|
FRDA
|
[NCBI]
|
7.38911e-06
|
|
|
TNFRSF1A
|
[NCBI]
|
7.21229e-06
|
|
|
SMN1
|
[NCBI]
|
7.15627e-06
|
|
|
HNF1A
|
[NCBI]
|
7.10093e-06
|
|
|
homocystinuria
|
[NCBI]
|
6.99225e-06
|
|
|
APC
|
[NCBI]
|
6.98252e-06
|
|
|
AIRE
|
[NCBI]
|
6.7315e-06
|
|
|
TYR
|
[NCBI]
|
6.58207e-06
|
|
|
MC1R
|
[NCBI]
|
6.39042e-06
|
|
|
IFNA1
|
[NCBI]
|
6.16218e-06
|
|
|
PCD
|
[NCBI]
|
5.56519e-06
|
|
|
von willebrand disease
|
[NCBI]
|
5.50491e-06
|
|
|
RET
|
[NCBI]
|
5.31932e-06
|
|
|
MBP
|
[NCBI]
|
5.22093e-06
|
|
|
HSCR1
|
[NCBI]
|
4.93546e-06
|
|
|
LPL
|
[NCBI]
|
4.14689e-06
|
|
|
HFE
|
[NCBI]
|
3.69414e-06
|
|
|
CHS
|
[NCBI]
|
3.38064e-06
|
|
|
CJD
|
[NCBI]
|
2.87216e-06
|
|
|
SLOS
|
[NCBI]
|
2.62515e-06
|
|
|
GHR
|
[NCBI]
|
2.17597e-06
|
|
|
SOD1
|
[NCBI]
|
2.14886e-06
|
|
|
APOE
|
[NCBI]
|
1.50297e-06
|
|
|
INS
|
[NCBI]
|
1.4816e-06
|
|
|
TPO
|
[NCBI]
|
1.24465e-06
|
|
|
FMF
|
[NCBI]
|
8.40734e-07
|
|
|
MODY
|
[NCBI]
|
7.01969e-07
|
|
|
TG
|
[NCBI]
|
6.23754e-07
|
|
|
ADA
|
[NCBI]
|
2.73259e-07
|
|
|
RTT
|
[NCBI]
|
2.5178e-07
|
|
|
ALD
|
[NCBI]
|
2.22533e-07
|
|
|
AR
|
[NCBI]
|
1.93168e-07
|
|
|
RP
|
[NCBI]
|
1.70129e-07
|
|
|
APOB
|
[NCBI]
|
1.17489e-07
|
|
|
COMT
|
[NCBI]
|
2.34257e-08
|
|
|
CD
|
[NCBI]
|
2.12805e-08
|
|
|
TTR
|
[NCBI]
|
1.01911e-09
|
|